jaundice internal medicine presentation

Upload: shitanjni-wati

Post on 09-Apr-2018

224 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    1/34

    HYPERBILIRUBINEMIAJAUNDICE

    (Icterus)

    Presenter: Abdul Mushib Ibrahim

    MBBS Year 4

    UPSM

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    2/34

    Definition

    Refers to YELLOWISH pigmentation of:

    SKIN

    SCLERAEMUCOSA

    -Due to increased levels of bilirubin in the blood.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    3/34

    VALUES

    NORMAL PLASMA Bilirubin:

    0.5mg/dl

    ABNORMAL PLASMA Bilirubin:

    > 1.5mg/dl or > 35micromoles/L

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    4/34

    Classification of Jaundice

    Jaundice is classified by1-Type of Circulating Bilirubin:

    a)Conjugated

    b)Unconjugated

    2-Site of Problem:

    a)Pre-Hepaticb)Hepatic

    c)Post Hepatic/Cholestatic/Obstructive

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    5/34

    RBC BREAK DOWNGLOBIN

    HEME

    biliverdin

    (greencolor)

    Unconjugated-

    bilirubin-yellow

    BLOOD STREAM

    LIVERConjugated

    Bilirubin

    UDP-glucuronyl

    transferase

    Bilary Tree &

    Cystic Duct->

    BILE

    Intestinal Bactria

    Urobilinogen

    stercobilin urobilin

    ALBUMIN

    YELLOW

    DISCOLOURATION

    OF SKIN

    1-Gilberts

    Syndrome

    2-Crigler Najjar

    Syndrome

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    6/34

    Uncongugated Bilirubin

    -Is water insoluble.

    -It does not enter urine.-Bound to plasma Albumin-> travels to Liver->to

    form congugated Bilirubin.

    -Results in ACHOLURIC Hyperbilirubinaemia.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    7/34

    Classification of Jaundice

    Jaundice is classified by1-Type of Circulating Bilirubin:

    a)Unconjugated

    b)Conjugated

    2-Site of Problem:

    a)Pre-Hepaticb)Hepatic

    c)Post Hepatic/Cholestatic/Obstructive

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    8/34

    Pre-Hepatic-Uncongugated

    The pathology is occurring prior to the liver

    caused by anything which causes an increasedrate of breakdown of red blood cells

    ISOLATED raised Bilirubin levels-(Uncongugated)

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    9/34

    Hemolytic Jaundice:

    Genetic diseases, such as:

    1-sickle cell anemia2-spherocytosis

    3-thalassemia

    4 glucose 6-phosphate dehydrogenasedeficiency

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    10/34

    Infective Causes:

    5-Malaria-In tropical countries

    6-Leptospirosis.

    Congenital Causes:

    7-Gilberts Syndrome8-Cringler Najjar Syndrome

    TYPE I

    TYPE II

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    11/34

    Classification of Jaundice

    1-Type of Circulating Bilirubin:

    a)Unconjugated

    b)Conjugated

    2-Site of Problem:

    a)Pre-Hepaticb)Hepatic

    c)Post Hepatic/Cholestatic/Obstructive

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    12/34

    Hepatic Jaundice-Congugated

    DEFINITION

    Results from the inability of the liver totransport bilirubin across the hepatocyte into

    the bile duct, occuring as a consequence of

    parenchymal liver disease.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    13/34

    Bilirubin transport is impaired because of:Uptake of Uncongugated Bilirubin into the cells

    Transport of Congugated Bilirubin into the Canaliculi.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    14/34

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    15/34

    In Hepatic Jaundice, concentrations of bothcongugated and Uncongugated Bilirubin

    increase.

    CARACTERISTICS OF HEPATIC JAUNDICE

    Increase in Transaminases AST (Aspartate Transaminase-5-35 iu/L)

    ALT (Alanine Aminotransferase-5-35iu/L)

    NOTE: Increase in other LFTS suggest other specificaetiologies.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    16/34

    Acute Jaundice in presence of AST > 1000U/L

    is HIGHLY SUGGESTIVE of:

    1. An Infectious Cause Hepatitis A, B,C, Alcoholic,

    CMV

    EBV

    2. Hepatic Ischaemia

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    17/34

    3. Drugs

    Paracetamol Overdose

    Isoniazid, Rifampicin, Pyrazinamide

    Monoamine Oxidase Inhibitors

    Sodium Valproate

    Halothane

    Statins

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    18/34

    Other Causes of Hepatic Jaundice

    4. Failure to excrete Congugated Bilirubin

    Dubin Johnson Syndrome

    Rotor Syndrome

    5-Sepsis ,hypoperfusion states

    6-Toxins

    Fungi-Amanita Phalloides

    Carbon Tetrachloride

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    19/34

    DIAGNOSING HEPATIC JAUNDICE

    Blood Test-LFTS

    Imaging-essential to identify features

    suggestive of cirrhosis. Irregular liver outline

    Splenomegaly

    Define Patency of Hepatic Arteries, Veins, Portal

    Vein.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    20/34

    Liver Biopsy-to define the cause of Hepatic

    Jaundice.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    21/34

    Classification of Jaundice

    1-Type of Circulating Bilirubin:

    a)Unconjugated

    b)Conjugated

    2-Site of Problem:

    a)Pre-Hepaticb)Hepatic

    c)Post Hepatic/Cholestatic/Obstructive

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    22/34

    POSTHEPATIC-Obstructive

    (Cholestatic) JaundiceCaused by:-Failure of hepatocytes to initiate bile flow.

    -Obstruction of Bile flow in bile ducts

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    23/34

    Disease States

    Obstructive Jaundice extrahepatic cholestasis

    Choledocholithiasis (CBD stone)

    Cancer (peri-ampullary or cholangio CA)

    Strictures after invasive procedures Acute and chronic pancreatitis

    Primary sclerosing cholangitis (PSC)

    Parasitic infections Ascaris lumbricoides, liver flukes

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    24/34

    Drug induced CholestatsisFlucloxacillin

    Augmentin

    Nitrofurantonin

    Steroids (Pill)

    Sulfonylureas

    Prochlorperazine

    Chlorpromazine.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    25/34

    Congugated BilirubinDark UrineBut less

    Congugated Bilirubin enters the gut thusfeaces is pale.

    When severeassociated with pruritis RX-

    relief of obstruction.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    26/34

    Cholestatic Jaundice is CHARACTERISED by:

    INCREASED: ALP -Alkaline Phosphatase-30-150

    GGT(-g- Glutamyl transpeptidaseU/S is indicated to determine mechnical

    obstruction & Dilatation of bilary tree.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    27/34

    EVALUATION

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    28/34

    Initial Evaluation: History

    Jaundice, pale stool, tea-colored urine Fever/chills, RUQ pain (cholangitis)

    Could lead to life-threatening septic shock

    Reasons to have hepatitis or cirrhosis? Alcohol, Viral, risk factors for viral hepatitis

    Exposure to toxins or offending drugs

    Inherited disorders or hemolytic conditions Recent blood transfusions or blood loss?

    Is patient septic?

    Recent gallbladder surgery? (CBD injury)

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    29/34

    Initial Evaluation: Physical Exam

    Signs of end stage liver disease (cirrhosis)

    Ascites, splenomegaly, spider angiomata, and

    gynecomastia

    Jaundice evident first underneath the tongue,

    also evident in sclerae or skin

    Courvoisiers sign = painless, but palpable or

    distended gallbladder on exam

    Could indicate malignant obstruction (e.g

    Pancretic Cancer)

    Unlikely to be caused by gallstone obstruction.

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    30/34

    Screening Labs

    URINE TEST-Bilirubin is absent in pre-hepatic cause.

    -Urobilinogen is absent in obstrcutive cause.

    HAEMATOLOGY

    -FBC

    -Clotting

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    31/34

    BIOCHEMISTRY

    -U&E LFT (Bilirubin,ALT,AST, ALK PHOS, GGT,

    Total Protein, Albumin)

    Alk Phos moreso than AST/ALT implies

    cholestasis (intrahepatic vs obstruction)

    Alk Phos also seen in sarcoid, TB, bone

    In this case, GGT is specific for biliary origin

    PredominantAST/ALT implies intrinsic

    hepatocellular disease AST/ALT ratio > 2 in alcoholic hepatitis

    albumin orINR c/w advanced liver dz

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    32/34

    Imaging for Obstructive Jaundice

    RUQ Ultrasound See stones, CBD diameter->6mmobstruction.

    ERCP

    Direct visualization of biliary tree/panc ducts Procedure of choice for choledocholithiasis

    Diagnostic AND- therapeutic

    Endoscopic Ultrasound CT scan

    Identify both type & level of obstruction

    If abdominal malignancy is suspected

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    33/34

    Treatment

    If Medical, then treat the etiology If Obstructive Jaundice:

    Ascending cholangitis For cholangitis: IVF, IV Antibiotics, Decompression

    Stones (remove stones vs stent vs drainage) Done via ERCP or open (surgery)

    Benign stricture (stent vs drainage catheter)

    Cancer (Stent vs drainage +/- resect the CA)

  • 8/7/2019 JAUNDICE Internal Medicine Presentation

    34/34

    THE END

    REFERANCE

    -DAVIDSONS-PRINCIPLES & PRACTICE OFMEDICINE

    -OXFORD HAND BOOK OF CLINICAL MEDICINE

    -WIKIPEDIA